Lucy-Novel Flavored Nicotine Gum, Lozenges, and Pouches: Are They Misleading Consumers?
- PMID: 35586938
- PMCID: PMC9451008
- DOI: 10.1080/10826084.2022.2076881
Lucy-Novel Flavored Nicotine Gum, Lozenges, and Pouches: Are They Misleading Consumers?
Abstract
Background: The packaging and marketing of nicotine gums, lozenges, and pouches can influence users' perceptions about which products are evidence-based for tobacco cessation and which are designed for nicotine maintenance-which could keep people nicotine dependent. Lucy, a company that produces flavored nicotine gums, lozenges, and pouches, could cause confusion by mimicking the packaging of traditional chewing gum and using similar marketing for its approved smoking cessation products and non-approved products. Methods: This commentary describes Lucy's marketing practices that could prolong nicotine dependence rather than aid cessation. Results: Lucy's marketing as "FDA approved for smoking cessation" (true for the lozenges but not the gum or pouches) and "PMTA [Premarket Tobacco Product Application] accepted" could create a false narrative of regulatory acceptance. Its scientific conference presentations could imply that it is endorsed by the scientific community. Its colorful pack design, emphasizing flavors and minimizing nicotine warnings, may attract youth and non-nicotine-users to initiate nicotine use. Conclusion: Lucy's promotion of its products as safe alternatives to other forms of tobacco, its packaging that recalls innocuous chewing gum, and its use of social media to advertise its products should be explored by researchers and considered by policymakers for potential population-level health effects.
Keywords: Tobacco; marketing; nicotine; regulation.
Conflict of interest statement
Declaration of interest
The authors declare that they have no conflict of interest. The authors alone are responsible for the content and writing of the article.
Figures
Similar articles
-
Use, marketing, and appeal of oral nicotine products among adolescents, young adults, and adults.Addict Behav. 2023 May;140:107632. doi: 10.1016/j.addbeh.2023.107632. Epub 2023 Jan 27. Addict Behav. 2023. PMID: 36731224
-
Oral Nicotine Gum Discussions on Twitter: Content Analysis.Nicotine Tob Res. 2024 Mar 22;26(4):503-507. doi: 10.1093/ntr/ntad190. Nicotine Tob Res. 2024. PMID: 37791822 Free PMC article.
-
New Product Marketing Blurs the Line Between Nicotine Replacement Therapy and Smokeless Tobacco Products.Am J Public Health. 2016 Jul;106(7):1219-22. doi: 10.2105/AJPH.2016.303057. Epub 2016 Apr 14. Am J Public Health. 2016. PMID: 27077338 Free PMC article.
-
Oral nicotine pouches for cessation or reduction of use of other tobacco or nicotine products.Cochrane Database Syst Rev. 2025 Feb 13;2(2):CD016220. doi: 10.1002/14651858.CD016220. Cochrane Database Syst Rev. 2025. PMID: 39945317 Free PMC article.
-
Treatment of nicotine dependence.Am J Health Syst Pharm. 1995 Feb 1;52(3):265-81; quiz 314-5. doi: 10.1093/ajhp/52.3.265. Am J Health Syst Pharm. 1995. PMID: 7749954 Review.
Cited by
-
Pharmaceuticalisation as the tobacco industry's endgame.BMJ Glob Health. 2024 Feb 5;9(2):e013866. doi: 10.1136/bmjgh-2023-013866. BMJ Glob Health. 2024. PMID: 38316465 Free PMC article.
-
Unclear Labeling of Nicotine Products Poses Risks to Consumers.Nicotine Tob Res. 2023 Apr 6;25(5):1057-1059. doi: 10.1093/ntr/ntac282. Nicotine Tob Res. 2023. PMID: 36511189 Free PMC article. No abstract available.
-
Patterns of oral nicotine pouch use among U.S. adolescents and young adults.Prev Med Rep. 2023 May 12;34:102239. doi: 10.1016/j.pmedr.2023.102239. eCollection 2023 Aug. Prev Med Rep. 2023. PMID: 37228836 Free PMC article.
-
The effect of CNQX on self-administration: present in nicotine, absent in methamphetamine model.Front Behav Neurosci. 2024 Jan 5;17:1305412. doi: 10.3389/fnbeh.2023.1305412. eCollection 2023. Front Behav Neurosci. 2024. PMID: 38249125 Free PMC article.
-
Oral Nicotine Pouches: Rising Popularity and State of the Science.Public Health Rep. 2025 Apr 28:333549251313668. doi: 10.1177/00333549251313668. Online ahead of print. Public Health Rep. 2025. PMID: 40293136 Free PMC article. Review.
References
-
- Apple Podcasts. (2019). "How to sell drugs" - A podcast from lucy. https://podcasts.apple.com/us/podcast/how-to-sell-drugs/id1457740508
-
- Coogan J (2022). Hey! I’m John Coogan, known for being the former Co-Founder at Soylent and most recently co-founder of Lucy Goods where we make intelligent nicotine alternatives, Ask me Anything! https://www.reddit.com/r/IAmA/comments/s8ojn8/hey_im_john_coogan_known_f...
-
- FDA Approved. (2021). https://help.lucy.co/article/6j5l1gbmlj-fda-approved.
-
- Food and Drug Administration (FDA). (2022a). Misleadingly labeled e-liquids that appeal to youth. https://www.fda.gov/tobacco-products/ctp-newsroom/misleadingly-labeled-e...
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical